(Q50525641)

English

Evaluation and optimization of the administration of a selectively replicating herpes simplex viral vector to the brain by convection-enhanced delivery

scientific article published on 4 March 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

Evaluation and optimization of the administration of a selectively replicating herpes simplex viral vector to the brain by convection-enhanced delivery (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

convection-enhanced delivery

0 references

author name string

E White

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

A Bienemann

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

L Megraw

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

C Bunnun

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

S Gill

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

publication date

4 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

18

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

358-369

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

The interface between glial progenitors and gliomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Molecular pathology of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Malignant glioma: patterns of failure following individually tailored limited volume irradiation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Stable levels of long-term transgene expression driven by the latency-associated transcript promoter in a herpes simplex virus type 1 vector

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Bioluminescence imaging after HSV amplicon vector delivery into brain.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Dynamic of migration of HSV-1 from a medullary pronociceptive centre: antinociception by overexpression of the preproenkephalin transgene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Drug inducible transgene expression in brain using a herpes simplex virus vector

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

A novel herpesvirus amplicon system for in vivo gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Quantitation of HSV mass distribution in a rodent brain tumor model.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Convection-enhanced delivery of macromolecules in the brain

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

CNS dendritic cells: critical participants in CNS inflammation?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Real-time MR imaging of adeno-associated viral vector delivery to the primate brain

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

21 January 2018

Epidemiology of primary brain tumors: current concepts and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2011.2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21372854

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50525641&oldid=2252140404"